Characterization of Cardiac Size and Function in SHRSP.Z-Leprfa/IzmDmcr Rats, a New Animal Model of Metabolic Syndrome-Reference-Cited by-同舟云学术

Characterization of Cardiac Size and Function in SHRSP.Z-Leprfa/IzmDmcr Rats, a New Animal Model of Metabolic Syndrome

Published:2010 Issue:12 Volume:33 Page:1971-1976
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Tada Yukari¹,Kagota Satomi¹,Matsumoto Mika²,Naito Yoshiro²,Shibata Hiromi³⁴,Nejime Namie¹,Tsujino Takeshi²,Koshiba Masahiro³,Masuyama Tohru²,Shinozuka Kazumasa¹

Affiliation:

1. Department of Pharmacology, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University

2. Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine

3. Department of Clinical Laboratory, Hyogo College of Medicine Hospital

4. School of Pharmacy, Hyogo University of Health Science

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

http://www.jstage.jst.go.jp/article/bpb/33/12/33_12_1971/_pdf

Reference39 articles.

1. Increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities – cross-sectional study of the general population

2. Obesity and the Risk of New-Onset Atrial Fibrillation

3. Impact of the Metabolic Syndrome on Atrial Size in Patients With New-Onset Atrial Fibrillation

4. Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass

5. Establishment of a new animal model of metabolic syndrome: SHRSP fatty (fa/fa) rats

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perivascular Adipose Tissue Compensation for Endothelial Dysfunction in the Superior Mesenteric Artery of Female SHRSP.Z-Leprfa/IzmDmcr Rats;Journal of Vascular Research;2022

2. A Sodium Glucose Cotransporter 2 Inhibitor Fails to Improve Perivascular Adipose Tissue-Mediated Modulation of Vasodilation and Cardiac Function in Rats With Metabolic Syndrome;Journal of Cardiovascular Pharmacology and Therapeutics;2021-03-25

3. Activation of protease‐activated receptor 2 is associated with blood pressure regulation and proteinuria reduction in metabolic syndrome;Clinical and Experimental Pharmacology and Physiology;2020-11-21

4. Non-alcoholic steatohepatitis aggravates nitric oxide synthase inhibition-induced arteriosclerosis in SHRSP5/Dmcr rat model;International Journal of Experimental Pathology;2018-12

5. Modeling heart failure risk in diabetes and kidney disease: limitations and potential applications of transverse aortic constriction in high-fat-fed mice;American Journal of Physiology-Regulatory, Integrative and Comparative Physiology;2018-06-01